Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases

British Journal of Pharmacology

Volumn 152, Issue 1, 2007, Pages 141-150

  Levesque S A ^a   Lavoie, E G ^a   Lecka, J ^a   Bigonnesse, F ^a   Sevigny J ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

ARL 67156; CD39; Ecto 5 nucleotidase; Ecto ATPase; Extracellular nucleotide; FPL 67156; NPP; NTPDase

Indexed keywords

ADENOSINE PHOSPHATE; BETA,GAMMA DIBROMOMETHYLENE 6 N,N DIETHYLADENOSINE TRIPHOSPHATE; NUCLEOTIDASE; PROTEIN NTPDASE 1; PROTEIN NTPDASE 2; PROTEIN NTPDASE 3; PROTEIN NTPDASE 8; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COLORIMETRY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME SPECIFICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD; APYRASE; DINUCLEOSIDE PHOSPHATES; ENZYME INHIBITORS; HUMANS; HYDROLYSIS; KINETICS; MICE; NUCLEOTIDASES; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; THYMIDINE MONOPHOSPHATE; URIDINE TRIPHOSPHATE;

EID: 34548319100     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707361     Document Type: Article

References (57)

1. Baykov AA, Evtushenko OA, Avaeva SM (1988). A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem 171: 266-270.
2. Belli SI, Goding JW (1994). Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities. Eur J Biochem 226: 433-443.
3. 2+-permeable channel activated by ATP in smooth muscle. Nature 328: 275-278.
4. Bigonnesse F, Levesque SA, Kukulski F, Lecka J, Robson SC, Fernandes MJ et al. (2004). Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 43: 5511-5519.
5. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. Buckley MF, Loveland KA, McKinstry WJ, Garson OM, Goding JW (1990). Plasma cell membrane glycoprotein PC-1. cDNA cloning of the human molecule, amino acid sequence, and chromosomal location. J Biol Chem 265: 17506-17511.
7. Burnstock G (2006). Purinergic signalling. Br J Pharmacol 147 (Suppl 1): S172-S181.
8. Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D et al. (2006). The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25: 4615-4627.
9. Cimpean A, Stefan C, Gijsbers R, Stalmans W, Bollen M (2004). Substrate-specifying determinants of the nucleotide pyrophosphatases/ phosphodiesterases NPP1 and NPP2. Biochem J 381: 71-77.
10. Connolly GP, Demaine C, Duley JA (1998). Ecto-nucleotidases in isolated intact rat vagi, nodose ganglia, and superior cervical ganglia. Adv Exp Med Biol 431: 769-776.
11. Connolly GP, Duley JA (2000). Ecto-nucleotidase of cultured rat superior cervical ganglia: dipyridamole is a novel inhibitor. Eur J Pharmacol 397: 271-277.
12. Crack BE, Pollard CE, Beukers MW, Roberts SM, Hunt SF, Ingall AH et al. (1995). Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br J Pharmacol 114: 475-481.
13. Dowd FJ, Li LS, Zeng W (1999). Inhibition of rat parotid ecto-ATPase activity. Arch Oral Biol 44: 1055-1062.
14. Drakulich DA, Spellmon C, Hexum TD (2004). Effect of the ecto-ATPase inhibitor, ARL 67156, on the bovine chromaffin cell response to ATP. Eur J Pharmacol 485: 137-140.
15. Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch II JS et al. (1999). Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5: 1010-1017.
16. Erga KS, Seubert CN, Liang HX, Wu L, Shryock JC, Belardinelli L (2000). Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart. Br J Pharmacol 130: 1065-1075.
17. Farahbakhsh NA (2003). Ectonucleotidases of the rabbit ciliary body nonpigmented epithelium. Invest Ophthalmol Vis Sci 44: 3952-3960.
18. Fausther M, Lecka J, Kukulski F, Lévesque SA, Pelletier J, Zimmermann H et al. (2007). Cloning, purification and identification of the liver canalicular ecto-ATPase as NTPDase8. Am J Physiol Gastroenterol Liver Physiol 292: G785-G795.
19. Ghildyal P, Manchanda R (2004). Effects of cooling and ARL 67156 on synaptic ecto-ATPase activity in guinea pig and mouse vas deferens. Auton Neurosci 115: 28-34.
20. Gijsbers R, Aoki J, Arai H, Bollen M (2003). The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett 538: 60-64.
21. Goding JW (2000). Ecto-enzymes: physiology meets pathology. J Leukoc Biol 67: 285-311.
22. Grobben B, Claes P, Roymans D, Esmans EL, Van Onckelen H, Slegers H (2000). Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists. Br J Pharmacol 130: 139-145.
23. He ML, Gonzalez-Iglesias AE, Tomic M, Stojilkovic SS (2005). Release and extracellular metabolism of ATP by ecto-nucleotidase eNTPDase 1-3 in hypothalamic and pituitary cells. Purinergic Signal 1: 135-144.
24. Iqbal J, Vollmayer P, Braun N, Zimmermann H, Müller CE (2005). A capillary electrophoresis method for the characterization of ectonucleoside triphosphate diphosphohydrolase (NTPDases) and the analysis of inhibition by in capillary enzymatic microreaction. Purinergic Signal 1: 349-358.
25. Jacobson KA, Gao ZG (2006). Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5: 247-264.
26. Jansen S, Stefan C, Creemers JW, Waelkens E, Van Eynde A, Stalmans W et al. (2005). Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J Cell Sci 118: 3081-3089.
27. Jin-Hua P, Goding JW, Nakamura H, Sano K (1997). Molecular cloning and chromosomal localization of PD-Ibeta (PDNP3), a new member of the human phosphodiesterase I genes. Genomics 45: 412-415.
28. Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR et al. (1996). Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271: 33116-33122.
29. Kegel B, Braun N, Heine P, Maliszewski CR, Zimmermann H (1997). An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology 36: 1189-1200.
30. Khakh BS, Michel AD, Humphrey PPA (1995). Inhibition of ecto-ATPase and Ca-ATPase in rat vas deferens by P2 purinoceptor antagonists. Br J Pharmacol 115: 2P.
31. Knowles AF, Chiang WC (2003). Enzymatic and transcriptional regulation of human ecto-ATPase/E-NTPDase 2. Arch Biochem Biophys 418: 217-227.
32. Kukulski F, Lévesque SA, Lavoie EG, Lecka J, Bigonnesse F, Knowles AF et al. (2005). Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal 1: 193-204.
33. Laitinen JT, Uri A, Raidaru G, Miettinen R (2001). [(35)S]GTPgammaS autoradiography reveals a wide distribution of G(i/o)-linked ADP receptors in the nervous system: close similarities with the platelet P2Y(ADP) receptor. J Neurochem 77: 505-518.
34. Lavoie EG, Kukulski F, Lévesque SA, Lecka J, Sévigny J (2004). Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-3. Biochem Pharmacol 67: 1917-1926.
35. Luthje J, Ogilvie A (1985). Catabolism of Ap3A and Ap4A in human plasma. Purification and characterization of a glycoprotein complex with 5′-nucleotide phosphodiesterase activity. Eur J Biochem 149: 119-127.
36. Machida T, Heerdt PM, Reid AC, Schafer U, Silver RB, Broekman MJ et al. (2005). Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis. J Pharmacol Exp Ther 313: 570-577.
37. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB et al. (1997). The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 99: 1351-1360.
38. McLaren GJ, Burke KS, Buchanan KJ, Sneddon P, Kennedy C (1998). Evidence that ATP acts at two sites to evoke contraction in the rat isolated tail artery. Br J Pharmacol 124: 5-12.
39. Mukasa T, Lee Y, Knowles AF (2005). Either the carboxyl- or the amino-terminal region of the human ecto-ATPase (E-NTPDase 2) confers detergent and temperature sensitivity to the chicken ecto-ATP-diphosphohydrolase (E-NTPDase 8). Biochemistry 44: 11160-11170.
40. Picher M, Sévigny J, D'Orleans-Juste P, Beaudoin AR (1996). Hydrolysis of P2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase. Biochem Pharmacol 51: 1453-1460.
41. Robson SC, Sévigny J, Zimmermann H (2006). The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2: 409-430.
42. Sesti C, Broekman MJ, Drosopoulos JH, Islam N, Marcus AJ, Levi R (2002). EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release. J Pharmacol Exp Ther 300: 605-611.
43. Sévigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, Qawi I et al. (2002). Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99: 2801-2809.
44. Silva G, Beierwaltes WH, Garvin JL (2006). Extracellular ATP stimulates NO production in rat thick ascending limb. Hypertension 47: 563-567.
45. Smith TM, Kirley TL (1998). Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases1. Biochim Biophys Acta 1386: 65-78.
46. Stefan C, Jansen S, Bollen M (2005). NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 30: 542-550.
47. Stefan C, Jansen S, Bollen M (2006). Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signal 2: 361-370.
48. Sträter N (2006). Ecto-5′-nucleotidase: structure function relationships. Purinergic Signal 2: 343-350.
49. Vollmayer P, Clair T, Goding JW, Sano K, Servos J, Zimmermann H (2003). Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/ phosphodiesterases. Eur J Biochem 270: 2971-2978.
50. von Kugelgen I (2006). Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432.
51. Wang TF, Ou Y, Guidotti G (1998). The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure. J Biol Chem 273: 24814-24821.
52. Westfall TD, Kennedy C, Sneddon P (1996). Enhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156. Br J Pharmacol 117: 867-872.
53. Westfall TD, Kennedy C, Sneddon P (1997a). The ecto-ATPase inhibitor ARL 67156 enhances parasympathetic neurotransmission in the guinea-pig urinary bladder. Eur J Pharmacol 329: 169-173.
54. Westfall TD, McIntyre CA, Obeid S, Bowes J, Kennedy C, Sneddon P (1997b). The interaction of diadenosine polyphosphates with P2x-receptors in the guinea-pig isolated vas deferens. Br J Pharmacol 121: 57-62.
55. Westfall TD, Menzies JR, Liberman R, Waterston S, Ramphir N, Westfall DP et al. (2000a). Release of a soluble ATPase from the rabbit isolated vas deferens during nerve stimulation. Br J Pharmacol 131: 909-914.
56. Westfall TD, Sarkar S, Ramphir N,Westfall DP, Sneddon P, Kennedy C (2000b). Characterization of the ATPase released during sympathetic nerve stimulation of the guinea-pig isolated vas deferens. Br J Pharmacol 129: 1684-1688.
57. Zimmermann H (2000). Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362: 299-309.